Targeted inhibition of HK1 or HK2 can inhibit the aerobic glycolysis of tumor cells, promote mitochondrial oxidative phosphorylation, and inhibit the proliferation and growth of tumor cells, which is a new strategy for tumor treatment (62–64). The gene discussed is HK1; the disease is neoplasm.